These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7599386)
1. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Schallreuter KU; Wood JM; Lemke KR; Levenig C Dermatology; 1995; 190(3):223-9. PubMed ID: 7599386 [TBL] [Abstract][Full Text] [Related]
2. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Schallreuter KU; Moore J; Behrens-Williams S; Panske A; Harari M Int J Dermatol; 2002 Aug; 41(8):482-7. PubMed ID: 12207762 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo. Bakis-Petsoglou S; Le Guay JL; Wittal R Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170 [TBL] [Abstract][Full Text] [Related]
4. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS. Schallreuter KU; Salem MA; Holtz S; Panske A FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of oxidative stress in vitiligo. Schallreuter KU Skin Pharmacol Appl Skin Physiol; 1999; 12(3):132-8. PubMed ID: 10393521 [TBL] [Abstract][Full Text] [Related]
6. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Patel DC; Evans AV; Hawk JL Clin Exp Dermatol; 2002 Nov; 27(8):641-4. PubMed ID: 12472535 [TBL] [Abstract][Full Text] [Related]
7. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887 [TBL] [Abstract][Full Text] [Related]
8. Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase. Kostović K; Pastar Z; Pasić A; Ceović R Acta Dermatovenerol Croat; 2007; 15(1):10-4. PubMed ID: 17433173 [TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. Schallreuter KU; Moore J; Wood JM; Beazley WD; Gaze DC; Tobin DJ; Marshall HS; Panske A; Panzig E; Hibberts NA J Investig Dermatol Symp Proc; 1999 Sep; 4(1):91-6. PubMed ID: 10537016 [TBL] [Abstract][Full Text] [Related]
10. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Asawanonda P; Klahan SO Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233 [TBL] [Abstract][Full Text] [Related]
11. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis. Li R; Qiao M; Wang X; Zhao X; Sun Q Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531 [TBL] [Abstract][Full Text] [Related]
12. Vitiligo--a window in the darkness. Westerhof W Dermatology; 1995; 190(3):181-2. PubMed ID: 7599377 [No Abstract] [Full Text] [Related]
13. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study. Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595 [TBL] [Abstract][Full Text] [Related]
14. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Bansal S; Sahoo B; Garg V Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425 [TBL] [Abstract][Full Text] [Related]
15. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of pseudocatalase formulations in vitiligo. Schallreuter KU Clin Exp Dermatol; 2003 Sep; 28(5):562-3; author reply 563. PubMed ID: 12950359 [No Abstract] [Full Text] [Related]
17. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB. Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486 [TBL] [Abstract][Full Text] [Related]
18. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004 [TBL] [Abstract][Full Text] [Related]
19. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Kullavanijaya P; Lim HW Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875 [TBL] [Abstract][Full Text] [Related]
20. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Majid I Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]